JP2019532050A5 - - Google Patents

Download PDF

Info

Publication number
JP2019532050A5
JP2019532050A5 JP2019514255A JP2019514255A JP2019532050A5 JP 2019532050 A5 JP2019532050 A5 JP 2019532050A5 JP 2019514255 A JP2019514255 A JP 2019514255A JP 2019514255 A JP2019514255 A JP 2019514255A JP 2019532050 A5 JP2019532050 A5 JP 2019532050A5
Authority
JP
Japan
Prior art keywords
tert
butyl
compound
benzamide
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019514255A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019532050A (ja
JP7068277B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/075875 external-priority patent/WO2018069362A1/en
Publication of JP2019532050A publication Critical patent/JP2019532050A/ja
Publication of JP2019532050A5 publication Critical patent/JP2019532050A5/ja
Application granted granted Critical
Publication of JP7068277B2 publication Critical patent/JP7068277B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019514255A 2016-10-14 2017-10-11 Eaat3阻害剤としてのイミダゾール化合物 Expired - Fee Related JP7068277B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16193871 2016-10-14
EP16193871.7 2016-10-14
PCT/EP2017/075875 WO2018069362A1 (en) 2016-10-14 2017-10-11 Imidazole compounds as eaat3 inhibitors

Publications (3)

Publication Number Publication Date
JP2019532050A JP2019532050A (ja) 2019-11-07
JP2019532050A5 true JP2019532050A5 (cg-RX-API-DMAC7.html) 2020-11-19
JP7068277B2 JP7068277B2 (ja) 2022-05-16

Family

ID=57136749

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019514255A Expired - Fee Related JP7068277B2 (ja) 2016-10-14 2017-10-11 Eaat3阻害剤としてのイミダゾール化合物

Country Status (5)

Country Link
US (1) US10556870B2 (cg-RX-API-DMAC7.html)
EP (1) EP3526201B1 (cg-RX-API-DMAC7.html)
JP (1) JP7068277B2 (cg-RX-API-DMAC7.html)
CN (1) CN109563049B (cg-RX-API-DMAC7.html)
WO (1) WO2018069362A1 (cg-RX-API-DMAC7.html)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5882926A (en) * 1993-10-20 1999-03-16 Oregon Health Sciences University Excitatory amino acid transporter gene and uses
JP2006151954A (ja) 2004-10-27 2006-06-15 Taisho Pharmaceut Co Ltd アスパラギン酸誘導体
US7939556B2 (en) 2005-10-14 2011-05-10 Neurosearch A/S Imidazole derivatives and their use for modulating the GABAA receptor complex
ES2596706T3 (es) 2006-06-29 2017-01-11 F. Hoffmann-La Roche Ag Arilamidas con sustitución de tetrazol
KR101186704B1 (ko) 2007-10-04 2012-09-27 에프. 호프만-라 로슈 아게 테트라졸-치환된 아릴 아마이드 유도체 및 이의 용도
WO2009058298A1 (en) * 2007-10-31 2009-05-07 Merck & Co., Inc. P2x3, receptor antagonists for treatment of pain
ES2570628T3 (es) * 2007-12-17 2016-05-19 Hoffmann La Roche Nuevas arilamidas con sustitución imidazol
KR101405746B1 (ko) 2007-12-17 2014-06-10 에프. 호프만-라 로슈 아게 트리아졸 치환된 아릴아미드 유도체 및 p2x3 및/또는 p2x2/3 퓨린성 수용체 길항제로서의 용도
DK2234976T3 (da) 2007-12-17 2013-06-24 Hoffmann La Roche Nye pyrazol-substituerede arylamider
TW201006801A (en) 2008-07-18 2010-02-16 Lilly Co Eli Imidazole carboxamides
US20110237578A1 (en) 2008-09-18 2011-09-29 Zhi-Liang Wei Amide compounds, compositions and uses thereof
CA2741666C (en) 2008-10-31 2017-04-11 Merck Sharp & Dohme Corp. P2x3, receptor antagonists for treatment of pain
EP3542813A1 (en) * 2013-05-31 2019-09-25 The A2 Milk Company Limited Beta-casein a2 and prevention of inflammation of the bowel
CN105555766A (zh) * 2013-07-18 2016-05-04 诺华股份有限公司 作为补体因子d抑制剂的氨基甲基-联芳基衍生物及其应用
US10577332B2 (en) 2015-04-23 2020-03-03 Hoffmann-La Roche Inc. Tetrazole derivatives
CN107531642B (zh) 2015-06-04 2021-06-22 豪夫迈·罗氏有限公司 咪唑衍生物
JP6846363B2 (ja) 2015-07-14 2021-03-24 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 2−フェニル−6−イミダゾリル−ピリジン−4−カルボキサミド誘導体及びそのeaat3阻害剤としての使用
WO2017025523A1 (en) 2015-08-12 2017-02-16 F. Hoffmann-La Roche Ag Pyridine and pyrimidine derivatives
WO2017060202A1 (en) 2015-10-06 2017-04-13 F. Hoffmann-La Roche Ag Triazole derivatives
ITUB20154829A1 (it) 2015-10-27 2017-04-27 Giuseppe Galtieri Dispositivo ad impulsi dinamici da traffico veicolare e relativo kit.
EP3411365B1 (en) 2016-02-02 2019-11-20 H. Hoffnabb-La Roche Ag Pyrazol-pyridine derivatives as eaat3 inhibitors
CN109071451B (zh) 2016-05-27 2022-07-15 豪夫迈·罗氏有限公司 作为eaat3抑制剂的吡唑化合物

Similar Documents

Publication Publication Date Title
JP2019094345A5 (cg-RX-API-DMAC7.html)
JP2016518437A5 (cg-RX-API-DMAC7.html)
JP2017533968A5 (cg-RX-API-DMAC7.html)
JP2019517487A5 (cg-RX-API-DMAC7.html)
JP2017526667A5 (cg-RX-API-DMAC7.html)
JP2005523922A5 (cg-RX-API-DMAC7.html)
JP2020507589A5 (cg-RX-API-DMAC7.html)
JP2020532547A5 (cg-RX-API-DMAC7.html)
JP2016505637A5 (cg-RX-API-DMAC7.html)
JP2013508279A5 (cg-RX-API-DMAC7.html)
JP2014502641A5 (cg-RX-API-DMAC7.html)
JP2014511891A5 (cg-RX-API-DMAC7.html)
JP2014511892A5 (cg-RX-API-DMAC7.html)
JP2008523041A5 (cg-RX-API-DMAC7.html)
JP2009531376A5 (cg-RX-API-DMAC7.html)
JP2016525102A5 (cg-RX-API-DMAC7.html)
JP2019520344A5 (cg-RX-API-DMAC7.html)
JP2017506237A5 (cg-RX-API-DMAC7.html)
JP2014505107A5 (cg-RX-API-DMAC7.html)
RU2017116197A (ru) 2-амино-3,5-дифтор-3,6-диметил-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1 для лечения болезни альцгеймера
JP2018537535A5 (cg-RX-API-DMAC7.html)
JP2020512337A5 (cg-RX-API-DMAC7.html)
JP2018534355A5 (cg-RX-API-DMAC7.html)
JP2015522018A5 (cg-RX-API-DMAC7.html)
RU2017116196A (ru) 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1